TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN UPDATE ON THE ANALYSIS OF MALIGNANCY RATES FROM THE ULCERATIVE COLITIS CLINICAL PROGRAMME AS OF MAY 2019

Gary Lichtenstein  1     Matthew A. Ciorba  2     Gerhard Rogler  3     Ala Sharara  4     Nancy Sunna  5     Rajiv Mundayat  6     Donna T Judd  7     Nervin Lawendy     Julian Panés  8    
1 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, United States
2 Washington University in St. Louis, St. Louis, United States
3 University of Zürich, Zürich, Switzerland
4 American University of Beirut Medical Center, Beirut, Lebanon
5 Pfizer, Amman, Jordan
6 Pfizer Inc, New York, United States
7 Pfizer Inc, Collegeville, United States
8 Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain

Topic
IBD

Session
IBD: Clinical trials II

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing